Status:
COMPLETED
Impact of Artificial Intelligence (AI) on Adenoma Detection During Colonoscopy in FIT+ Patients.
Lead Sponsor:
Valduce Hospital
Conditions:
Polyp of Colon
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
The Italian screening program invites the resident population aged 50-74 for Fecal Immunochemical Test (FIT) every 2 years. Subjects who test positive are referred for colonoscopy. Maximizing adenoma ...
Eligibility Criteria
Inclusion
- Consecutive adult (50-74 yrs.) outpatients undergoing colonoscopy in the frame of the FIT-based screening program.
Exclusion
- patients with CRC history or hereditary polyposis syndromes or hereditary non-polyposis colorectal cancer
- patients with inadequate bowel preparation
- patients in which cecal intubation was not achieved or scheduled for partial examinations
- patients with gastrointestinal symptoms
- polyps could not be resected due to ongoing anticoagulation preventing resection and pathological assessment
Key Trial Info
Start Date :
December 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT04691401
Start Date
December 20 2020
End Date
December 31 2021
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology Unit, Valduce Hospital
Como, Italy, 22100